MichelleElizabethMeliskoMD
Oncology • San Francisco, CABreast Cancer, Hematologic Oncology, Hospice & Palliative
Clinical Professor, Medicine, UCSF School of Medicine
Dr. Melisko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-353-7070Fax+1 415-353-9898
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2000 - 2003
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1997 - 2000
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1997
Certifications & Licensure
CA State Medical License 1998 - 2026- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases Start of enrollment: 2005 Feb 01
- Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients Start of enrollment: 2007 Mar 01
- Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast Cancer Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer.Anna Northrop, Anika Christofferson, Saumya Umashankar, Michelle Melisko, Paolo Castillo
Journal of the American Medical Informatics Association. 2025-01-01 - NCCN Guidelines® Insights: Survivorship, Version 2.2024.Tara Sanft, Andrew T Day, Mindy Goldman, Shannon Ansbaugh, Saro Armenian
Journal of the National Comprehensive Cancer Network. 2024-12-01 - Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways.Kate R Oppegaard, Yvette P Conley, Steven Paul, Bruce Cooper, Carolyn S Harris
Journal of Neural Transmission. 2024-09-26
Press Mentions
Brain Metastasis Screening in MBC: Navigating Challenges in Clinical Decision-MakingDecember 16th, 2024
ESMO Breast Cancer Roundtable: Episode 5November 13th, 2019
OncLive® Presents the Latest State of the Science Summit™ on Breast CancerSeptember 25th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
